Inspire Medical Systems, Inc. (INSP)

NYSE: INSP · USD

$71.1

-0.22 (-0.3%)· Recorded snapshot

Market cap	2.1B
Revenue (ttm)	898.7M
Net income (ttm)	135M
EPS (ttm)	$4.61
Shares out	28.9M
P/E (trailing)	15.4x
P/E (forward)	52.6x
Volume	238,650
Beta	0.73

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 898.7M
Net income (ttm): 135M
EPS (ttm): $4.61
P/E (trailing): 15.4x
P/E (forward): 52.6x
Market cap: 2.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E52.6

P25 13.4P50 20.2P75 35.7

Trailing P/E15.4

P25 15.4P50 25.8P75 43.5

ROE18

P25 -113.8P50 -46.5P75 -0.9

ROIC10.1

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All INSP indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001609550
Company name	Inspire Medical Systems, Inc.
Country	United States
Country code	US
CUSIP number	457730109
Earnings date	2026-11-02
Earnings time	amc
Employees	1,333
Employees change	87
Employees growth	6.98%
Enterprise value	$1.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2007
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2018-05-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US4577301090
Last 10-K release date	2026-02-13
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$71.08
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	INSP
U.S. state	Minnesota
Website	https://www.inspiresleep.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	31.31x
Average P/E ratio (3Y)	131.96x
Earnings yield	6.48%
EV/Earnings	13.13x
EV/EBIT	32.76x
EV/EBITDA	24.86x
EV/FCF	15.14x
EV/Sales	1.97x
FCF / EV yield	6.6%
FCF yield	5.67%
Forward EV/Sales	2.05x
Forward P/E	52.64x
Forward P/S	2.39x
Graham number	54.4112
Graham upside	-23.82%
Industry forward P/E	19.74x
Industry P/E	39.16x
P/(OCF - SBC) ratio	54.8x
P/B ratio	2.5x
P/E ratio	15.43x
P/FCF ratio	17.63x
P/OCF ratio	13.15x
P/S ratio	2.3x
Price / tangible book value	2.5x
Price/EBITDA ratio	28.95x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.02%
EBITDA margin	7.94%
FCF margin	13.03%
Gross margin	86.13%
Operating margin	6.02%
Pretax margin	7.72%
Profit margin	15.03%
Profit per employee	$101,307
Profitable quarters	1
Profitable years	2
Revenue per employee	$674,225
ROA	3.91%
ROA (5Y)	-2.57%
ROCE	6.33%
ROE	17.96%
ROE (5Y)	-1.28%
ROIC	10.1%
ROIC (5Y)	-42.63%
SBC / revenue	13.28%
Tax / revenue	-7.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	164.44%
EPS growth quarters	1
EPS growth years	3
FCF growth	37.74%
FCF growth (QoQ)	350.46%
FCF growth 3Y	83.5%
Gross profit growth	6.4%
Gross profit growth (Q)	-6.01%
Gross profit growth 3Y	20.72%
Gross profit growth 5Y	38.98%
Net income growth	154.22%
Net income growth quarters	1
Net income growth years	3
OCF growth	33.74%
OCF growth (Q)	765.43%
OCF growth (QoQ)	80.78%
OCF growth 3Y	66.52%
Operating income growth	30.73%
Revenue growth	4.35%
Revenue growth (Q)	-7.6%
Revenue growth (QoQ)	-1.96%
Revenue growth 3Y	19.54%
Revenue growth 5Y	38.69%
Revenue growth years	10

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-40M
Depreciation and amortization	$17.2M
EBIT	$54.1M
EBITDA	$71.3M
EPS	$4.61
FCF per share	$4.05
Financing cash flow	$-105M
Free cash flow	$117.1M
Free cash flow minus SBC	$-2.3M
Gross profit	$774.1M
Income taxes	$-65.7M
Investing cash flow	$-31.3M
Net cash flow	$20.8M
Net income	$135M
Operating cash flow minus SBC	$37.7M
Operating income	$54.1M
Revenue	$898.7M
Stock-based compensation	$119.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	15.39
Book value per share	$28.56
Debt / EBITDA	0.37
Debt / equity	0.04
Debt / FCF	0.25
Interest coverage	395.06
Long-term assets	$317.3M
Long-term liabilities	$29.2M
Net cash (debt)	$291.6M
Net cash / market cap	14.12%
Net cash growth	8.87%
Net debt / EBITDA	-4.09
Net debt / equity	-0.35
Net debt / FCF	-2.49
Piotroski F-Score	6
Property, plant and equipment	$126.9M
Shareholders' equity	$825.6M
Tangible book value	$825.6M
Tangible book value per share	$28.56
Total assets	$926M
Total cash	$320.7M
Total debt	$29.1M
Total liabilities	$100.4M
WACC	8.16%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.04
Current assets	$608.7M
Current liabilities	$71.2M
Current ratio	8.55
Inventory turnover	0.85
Net working capital	$216.8M
Quick ratio	5.96
Working capital	$537.5M
Working capital turnover	1.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.84%
Dividend yield	0%
Shareholder yield	3.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$55.78
1D price change	-0.31%
1M price change	1.62%
1M total return	1.62%
1W price change	0.43%
1W total return	0.43%
1Y price change	-8.38%
1Y return CAGR	-8.39%
1Y total return	-8.38%
20-day SMA	$70.02
200-day SMA	$58.81
3M price change	40.67%
3M total return	40.67%
3Y price change	-52.5%
3Y return CAGR	-21.97%
3Y total return	-52.5%
50-day SMA	$68.28
50-day SMA vs 200-day SMA	50over200
52-week high	$147.03
52-week high date	2025-12-10
52-week low	$38.91
52-week low date	2026-06-03
5Y price change	-72.35%
5Y return CAGR	-22.67%
5Y total return	-72.35%
6M price change	30.1%
6M total return	30.1%
All-time high	$330.00
All-time high date	2023-07-14
All-time low	$22.50
All-time low date	2018-05-03
Average true range (ATR)	$2.83
Average volume	764.8K
Beta (1Y)	1.64
Beta (2Y)	0.89
Beta (5Y)	0.73
Change from 52-week high	-51.66%
Change from 52-week low	82.68%
Change from all-time high	-78.29%
Change from all-time low	218.42%
Change from open	0.64%
Day's gap	-0.94%
Dollar volume	$17M
High price	$71.77
Low price	$70.63
Monthly RSI	41.84
Open price	$70.63
Position in 52-week range	39.47%
Premarket change	0.01%
Premarket close	$71.30
Premarket price	$71.31
Previous close	$71.30
Price vs 150-day SMA	28.44%
Price vs 20-day SMA	2.33%
Price vs 200-day SMA	21.83%
Price vs 50-day SMA	4.93%
Relative volume	0.31
RSI	55.4
Sharpe ratio	0.16
Sharpe ratio (3Y)	-0.08
Sharpe ratio (5Y)	-0.17
Sortino ratio	0.35
Sortino ratio (3Y)	-0.03
Sortino ratio (5Y)	-0.14
Volume	238.7K
Weekly RSI	57.71
YTD price change	-22.32%
YTD total return	-22.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23.3M
Float percentage	80.49%
Shares change (QoQ)	0.84%
Shares change (YoY)	-3.84%
Shares held by insiders	1.29%
Shares held by institutions	111.09%
Shares outstanding	28.9M
Short % of float	18.03%
Short % of shares	14.51%
Short ratio	5 days

Deeper analysis on INSP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this INSP report

Is a complete INSP research report available?

No complete published report is available for Inspire Medical Systems, Inc. (INSP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Inspire Medical Systems, Inc. (INSP)

Price

Financial snapshot

Fair-value bridge

Latest news · INSP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INSP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INSP

Frequently asked questions